Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 19/20 | 0.49 |
| ▸ | MAOA | P21397 | 6/20 | 0.49 |
| ▸ | MAOB | P27338 | 11/20 | 0.48 |
| ▸ | CISD1 | Q9NZ45 | 1/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.47 |
| ▸ | HTR1B | P28222 | 1/20 | 0.47 |
| ▸ | HTR2A | P28223 | 1/20 | 0.47 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.47 |
| ▸ | KDM1B | Q8NB78 | 1/20 | 0.43 |
| ▸ | RCOR1 | Q9UKL0 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14880918 | 0.69 | KDM1A (0.50) | KDM1AMAOAMAOBCISD1SLC6A2 | |
| SCHEMBL14880898 | 0.67 | KDM1A (0.59) | KDM1AMAOAMAOBCISD1SLC6A2 | |
| SCHEMBL14880897 | 0.67 | KDM1A (0.59) | KDM1AMAOAMAOBCISD1SLC6A2 | |
| SCHEMBL16407926 | 0.67 | KDM1A (0.59) | KDM1AMAOAMAOBCISD1SLC6A2 | |
| SCHEMBL14880424 | 0.66 | KDM1A (1.00) | KDM1AMAOAMAOBCISD1SLC6A2 | |
| SCHEMBL14880932 | 0.66 | KDM1A (1.00) | KDM1AMAOAMAOBCISD1SLC6A2 | |
| SCHEMBL20580482 | 0.66 | KDM1A (1.00) | KDM1AMAOAMAOBCISD1SLC6A2 | |
| SCHEMBL14880741 | 0.66 | KDM1A (1.00) | KDM1AMAOAMAOBCISD1SLC6A2 | |
| SCHEMBL20580481 | 0.66 | KDM1A (1.00) | KDM1AMAOAMAOBCISD1SLC6A2 | |
| SCHEMBL14880581 | 0.66 | KDM1A (1.00) | KDM1AMAOAMAOBCISD1SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3736265-A1 | (HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS | Oryzon Genomics, S.A. (ES) | 2020-11-11 | — | — | EP | disclosed |
| EP-2768805-B1 | (HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS | ORYZON GENOMICS SA (ES) | 2020-03-25 | — | — | EP | disclosed |
| US-9944601-B2 | (Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors | ORYZON GENOMICS, S.A. (ES) | 2018-04-17 | — | — | US | disclosed |